BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.

Apellis Pharmaceuticals, Inc. faces a Sell rating amid revenue stagnation, Syfovre challenges, and uncertain long-term profit ...

The investment sets the stage for accelerated growth and value creation for ALLEGRIA. The funds will be used to progress its lead program towards pre-clinical candidates in support of nomination its ...

European legislators have reached a deal on a major rewrite of the region's pharma policies, pushing forward a framework ...

Both parties' notices of termination follow a ruling from the Treasurer of Australia blocking the proposed transaction and the expiry of the end date under the Scheme Implementation Deed in November.

A new report warns of the dangers of relying on China for key parts of essential medicines and calls for the creation of an ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently put under a microscope. Cramer said that “you’d do very well” owning the stock, as he stated: “If you want to venture beyond what ...

Danaher posted higher third-quarter earnings and said it expects pharmaceutical companies to increase research-and-development spending as tariff uncertainty eases. “We do see the tariff situation ...

BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered ...